CY1111813T1 - Αντικαρκινικο εμβολιο που περιλαμβανει αλλογονιδιακα ή ξενογονιδιακα καρκινικα κυτταρα - Google Patents
Αντικαρκινικο εμβολιο που περιλαμβανει αλλογονιδιακα ή ξενογονιδιακα καρκινικα κυτταραInfo
- Publication number
- CY1111813T1 CY1111813T1 CY20111100297T CY111100297T CY1111813T1 CY 1111813 T1 CY1111813 T1 CY 1111813T1 CY 20111100297 T CY20111100297 T CY 20111100297T CY 111100297 T CY111100297 T CY 111100297T CY 1111813 T1 CY1111813 T1 CY 1111813T1
- Authority
- CY
- Cyprus
- Prior art keywords
- carcinoma
- cancer
- allogonidic
- xenogenic
- vaccine including
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 201000011510 cancer Diseases 0.000 title abstract 2
- 229940022399 cancer vaccine Drugs 0.000 title 1
- 201000009030 Carcinoma Diseases 0.000 abstract 8
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 230000000735 allogeneic effect Effects 0.000 abstract 1
- 230000002962 histologic effect Effects 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 230000005847 immunogenicity Effects 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5152—Tumor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Zoology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Semiconductor Lasers (AREA)
Abstract
Η παρούσα εφεύρεση δίδει μια σύνθεση για την θεραπευτική αγωγή ενός καρκινώματος, η οποία περιλαμβάνει: (i) αλλογονιδιακά ή ξενογονιδιακά κύτταρα καρκινώματος • και (ii) ένα φαρμακευτικά αποδεκτό έκδοχο. Αν δύο ή περισσότερα ετερόζυγα άτομα έχουν τον ίδιο καρκίνο/καρκίνωμα του ίδιου ή παρόμοιου ιστολογικού βαθμού, τότε η μεταμόσχευση καρκινώματος καρκινικού ιστού/κυττάρων από το ένα άτομο στο άλλο δεν θα προκαλέσει μόνο απόρριψη του μεταμοσχευμένου ιστού/καρκινώματος, αλλά θα αυξήσει επίσης την ανοσοποιητική ετοιμότητα του ανοσοποιητικού συστήματος σε πεπτίδια που μοιράζονται μεταξύ καρκινωμάτων/καρκίνων και άλλων καρκινωμάτων, τα οποία διαθέτουν παρόμοια πεπτίδια.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0601598.6A GB0601598D0 (en) | 2006-01-26 | 2006-01-26 | Method |
| EP07712123A EP1993595B1 (en) | 2006-01-26 | 2007-01-26 | Tumour vaccine comprising allogeneic or xenogeneic tumour cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1111813T1 true CY1111813T1 (el) | 2015-10-07 |
Family
ID=36060924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20111100297T CY1111813T1 (el) | 2006-01-26 | 2011-03-17 | Αντικαρκινικο εμβολιο που περιλαμβανει αλλογονιδιακα ή ξενογονιδιακα καρκινικα κυτταρα |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US8105582B2 (el) |
| EP (1) | EP1993595B1 (el) |
| JP (2) | JP5635733B2 (el) |
| CN (1) | CN101405025B (el) |
| AT (1) | ATE492287T1 (el) |
| AU (1) | AU2007209301B9 (el) |
| BR (1) | BRPI0707247B8 (el) |
| CA (1) | CA2637690C (el) |
| CY (1) | CY1111813T1 (el) |
| DE (1) | DE602007011405D1 (el) |
| DK (1) | DK1993595T3 (el) |
| ES (1) | ES2358223T3 (el) |
| GB (1) | GB0601598D0 (el) |
| HK (1) | HK1130693A1 (el) |
| IL (1) | IL192964A (el) |
| NO (1) | NO338766B1 (el) |
| NZ (1) | NZ569942A (el) |
| PL (1) | PL1993595T3 (el) |
| PT (1) | PT1993595E (el) |
| RU (1) | RU2456997C2 (el) |
| SI (1) | SI1993595T1 (el) |
| WO (1) | WO2007085648A1 (el) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008299318A1 (en) | 2007-09-12 | 2009-03-19 | The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center | Methods of treating tumors in immune-privileged sites |
| WO2009094387A1 (en) * | 2008-01-22 | 2009-07-30 | Ghc Research Development Corporation | Compositions and methods for inducing tumor resistance |
| AU2012257377B2 (en) | 2011-05-17 | 2017-09-07 | Hadasit Medical Research Services And Development Ltd. | Allogeneic tumor cell vaccination |
| AU2020395765A1 (en) | 2019-12-03 | 2022-06-16 | Neuvogen, Inc. | Tumor cell vaccines |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6130520A (ja) * | 1984-07-19 | 1986-02-12 | Takeda Chem Ind Ltd | 抗腫瘍剤 |
| CN1006758B (zh) * | 1985-04-01 | 1990-02-14 | 哈达·克威斯 | 抗肿瘤药物组合物的制造方法 |
| JPH04501663A (ja) | 1988-09-23 | 1992-03-26 | ユニバーシティ・オブ・サザン・カリフォルニア | 黒色腫用免疫療法ワクチン |
| GB9827103D0 (en) | 1998-12-10 | 1999-02-03 | Onyvax Ltd | New cancer treatments |
| AU2003260426A1 (en) | 2002-08-16 | 2004-03-11 | Glycotope Gmbh | Process for the production of temperature-induced tumor cell lysates for use as immunogenic compounds |
-
2006
- 2006-01-26 GB GBGB0601598.6A patent/GB0601598D0/en not_active Ceased
-
2007
- 2007-01-26 WO PCT/EP2007/050807 patent/WO2007085648A1/en active Application Filing
- 2007-01-26 CN CN200780009893.4A patent/CN101405025B/zh active Active
- 2007-01-26 EP EP07712123A patent/EP1993595B1/en active Active
- 2007-01-26 AT AT07712123T patent/ATE492287T1/de active
- 2007-01-26 DE DE602007011405T patent/DE602007011405D1/de active Active
- 2007-01-26 DK DK07712123.4T patent/DK1993595T3/da active
- 2007-01-26 CA CA2637690A patent/CA2637690C/en active Active
- 2007-01-26 RU RU2008130457/15A patent/RU2456997C2/ru active
- 2007-01-26 US US12/161,418 patent/US8105582B2/en active Active
- 2007-01-26 JP JP2008551800A patent/JP5635733B2/ja active Active
- 2007-01-26 ES ES07712123T patent/ES2358223T3/es active Active
- 2007-01-26 PL PL07712123T patent/PL1993595T3/pl unknown
- 2007-01-26 BR BRPI0707247A patent/BRPI0707247B8/pt active IP Right Grant
- 2007-01-26 PT PT07712123T patent/PT1993595E/pt unknown
- 2007-01-26 SI SI200730526T patent/SI1993595T1/sl unknown
- 2007-01-26 AU AU2007209301A patent/AU2007209301B9/en active Active
- 2007-01-26 NZ NZ569942A patent/NZ569942A/en unknown
-
2008
- 2008-07-22 IL IL192964A patent/IL192964A/en active IP Right Grant
- 2008-08-13 NO NO20083519A patent/NO338766B1/no unknown
-
2009
- 2009-10-08 HK HK09109358.8A patent/HK1130693A1/xx unknown
-
2011
- 2011-03-17 CY CY20111100297T patent/CY1111813T1/el unknown
-
2012
- 2012-08-03 JP JP2012172672A patent/JP2012214499A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kuai et al. | Designer vaccine nanodiscs for personalized cancer immunotherapy | |
| Pancione et al. | Immune escape mechanisms in colorectal cancer pathogenesis and liver metastasis | |
| Abu Eid et al. | Enhanced therapeutic efficacy and memory of tumor-specific CD8 T cells by ex vivo PI3K-δ inhibition | |
| Tang et al. | Increased CD8+ T-cell function following castration and immunization is countered by parallel expansion of regulatory T cells | |
| Chiriva-Internati et al. | Cancer testis antigen vaccination affords long-term protection in a murine model of ovarian cancer | |
| EA201991692A1 (ru) | Иммуносконструированные плюрипотентные клетки | |
| CY1118629T1 (el) | Εμβολιο ιου ερπητα ζωστηρα | |
| ATE522600T1 (de) | Anti-tumor impfstoff aus normalen chemisch modifizierten cd4+ zellen | |
| ES2337399T3 (es) | Peptidos asociados a tumores unidos promiscuamente a moleculas del antigeno de leucocito humano (hla) de clase ii. | |
| WO2006023598A3 (en) | Prostate-specific antigen-derived mhc class ii-restricted peptides and their use in vaccines to treat or prevent prostate cancer | |
| ATE494303T1 (de) | An humane leukozytenantigen-(hla-)klasse-i- oder ii-moleküle bindende tumorassoziierte peptide und damit im zusammenhang stehender impfstoff gegen krebs | |
| ATE512160T1 (de) | T-cell-epitope aus dem unreifen lamininrezeptorprotein (oncofoetal antigen) und deren medizinische verwendungen | |
| CY1111813T1 (el) | Αντικαρκινικο εμβολιο που περιλαμβανει αλλογονιδιακα ή ξενογονιδιακα καρκινικα κυτταρα | |
| WO2009135199A3 (en) | Vaccine compositions and methods | |
| WO2008108910A3 (en) | Negative genetic regulation of cancer cell renewal in synergy with notch- or numb-specific immunotherapy | |
| WO2009114085A3 (en) | Allogeneic cancer cell-based immunotherapy | |
| EA200970607A1 (ru) | Универсальная вакцина из опухолевых клеток для противораковой терапии и профилактического использования | |
| WO2007130555A3 (en) | Augmentation of immune response to cancer vaccine | |
| AR068984A1 (es) | Proceso para la obtencion de celulas presentadoras de antigenos activados, utiles en las terapias contra el cancer y enfermedades relacionadas del sistema inmunologico | |
| EA200900738A1 (ru) | Слитые белки, содержащие антигены отторжения опухоли ny-eso-1 и lage-1 | |
| TR201818784T4 (tr) | Selenyum İle Kombinasyon Halinde Aronia Sp.'nin Bir Ekstraktını İçeren Bağışık Uyarıcı Terkip | |
| RU2013143741A (ru) | Терапевтическая вакцина против рака | |
| WO2006120473A3 (en) | Mhc class i and ii peptide antigens derived from tumour antigen 5t4 | |
| WO2009072555A1 (ja) | 癌ワクチン | |
| NO20084579L (no) | Fremgangsmate for vaksinering av individer som mottar immunmodulerende terapi |